What Does Wegovy Do? UK Mechanism & Results - From £69.00

Clinically Proven UK Registered Pharmacy

Cheapest What Does Wegovy Do UK Price - From £69.00

Discover what Wegovy does at the cheapest UK price from £69.00 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

What Does Wegovy Do for Weight Loss in the UK?

Understanding what does Wegovy do is essential for anyone considering this prescription weight loss treatment in the UK. Wegovy (semaglutide 2.4mg) is a once-weekly injectable medication that mimics a natural gut hormone called GLP-1, helping regulate appetite, reduce hunger signals, and slow gastric emptying to support significant weight loss when combined with lifestyle changes[1]. Available from Cured Pharmacy at £69.00 following clinical assessment by our UK-registered prescribers, Wegovy has demonstrated remarkable efficacy in clinical trials with patients losing an average of 15% of their body weight over 68 weeks[2].

How Does Wegovy Do Its Work in Your Body?

What does Wegovy do at the molecular level? Semaglutide, the active pharmaceutical ingredient in Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist that binds to GLP-1 receptors throughout your body, particularly in areas of the brain that regulate appetite and food intake[1]. When you inject Wegovy subcutaneously once weekly, it activates these receptors in the hypothalamus and brainstem, reducing hunger signals and increasing feelings of fullness after smaller portions.

The medication also slows gastric emptying, meaning food stays in your stomach longer, which prolongs satiety between meals[3]. Clinical pharmacology studies show that semaglutide has a half-life of approximately one week, allowing for convenient once-weekly dosing whilst maintaining steady therapeutic levels in your bloodstream. This sustained action is what makes Wegovy particularly effective compared to older weight loss treatments that required multiple daily doses.

What Does Wegovy Do in Clinical Trials? Real Results

The STEP clinical trial programme provides robust evidence of what Wegovy does for weight loss in real-world conditions. In the landmark STEP 1 trial involving 1,961 adults with obesity, participants using Wegovy 2.4mg weekly lost an average of 14.9% of their initial body weight over 68 weeks, compared to just 2.4% in the placebo group[2]. Notably, 83.5% of Wegovy users achieved at least 5% weight loss, whilst 66.1% lost 10% or more.

What does Wegovy do beyond the scales? The STEP trials also demonstrated significant improvements in cardiometabolic risk factors, including reductions in waist circumference (average 13.5cm decrease), improvements in blood pressure, and better glycaemic control markers even in participants without diabetes[4]. These comprehensive benefits reflect semaglutide's multi-system effects on metabolism, appetite regulation, and cardiovascular health, all contributing to sustainable weight management when combined with reduced-calorie diet and increased physical activity.

What Does Wegovy Do for Different BMI Categories?

Subgroup analyses from the STEP trials reveal that what Wegovy does varies slightly across different patient populations. Individuals with higher baseline BMI (35-40 kg/m²) experienced absolute weight losses of 18-22kg on average, whilst those with BMI 30-35 kg/m² typically lost 12-16kg over the same period[2]. The medication is licensed in the UK for adults with BMI ≥30 kg/m², or ≥27 kg/m² with at least one weight-related comorbidity such as hypertension or type 2 diabetes, subject to prescriber assessment.

What Does Wegovy Do to Your Appetite and Eating Behaviour?

Beyond physiological mechanisms, what does Wegovy do to change your relationship with food? Patient-reported outcomes from clinical trials consistently show that semaglutide reduces food cravings, particularly for high-fat and high-sugar foods, and decreases the frequency of loss-of-control eating episodes[5]. Functional MRI studies demonstrate that GLP-1 receptor agonists like Wegovy reduce neural activation in brain reward centres when participants view images of calorie-dense foods.

Many patients describe feeling satisfied with smaller portions and experiencing reduced preoccupation with food throughout the day. This psychological component is what makes Wegovy particularly effective for individuals who have struggled with appetite control on previous diets. However, it's crucial to understand that Wegovy is not an appetite suppressant in the traditional sense—it works by restoring normal satiety signals that may be dysregulated in obesity, rather than artificially suppressing hunger.

What Does Wegovy Do During the Dose Escalation Phase?

The Wegovy treatment protocol involves gradual dose escalation over 16-20 weeks, starting at 0.25mg weekly and increasing monthly to the maintenance dose of 2.4mg[6]. This staged approach is what does Wegovy's safety profile justice—it allows your body to adapt to increasing GLP-1 receptor activation whilst minimising gastrointestinal side effects like nausea and vomiting. Most patients begin noticing appetite reduction and modest weight loss even during the lower-dose initiation phase, with more pronounced effects emerging as they reach the 1.7mg and 2.4mg doses.

Treatment Mechanism Frequency Starting Price
Wegovy (Semaglutide) GLP-1 agonist - reduces appetite, slows gastric emptying Weekly injection From £89.00
Wegovy Oral Tablets GLP-1 agonist - oral semaglutide formulation Daily tablet From £83.00
Mounjaro (Tirzepatide) Dual GLP-1/GIP agonist - enhanced metabolic effects Weekly injection From £145.00
Saxenda (Liraglutide) GLP-1 agonist - appetite suppression Daily injection From £68.00
Orlistat Lipase inhibitor - blocks fat absorption Three times daily From £32.00
Mysimba Naltrexone/bupropion - reduces cravings Twice daily tablet From £125.95

What Does Wegovy Do Compared to Other Weight Loss Treatments?

When patients ask what does Wegovy do differently from alternatives like Orlistat or Saxenda, the answer lies in both mechanism and magnitude of effect. Orlistat works peripherally in the gut to block fat absorption, achieving average weight loss of 3-5% over 12 months[7]. Saxenda (liraglutide 3mg), another GLP-1 agonist, requires daily injections and produces average weight loss of 8-9% over 56 weeks. Wegovy's once-weekly semaglutide formulation delivers superior weight loss outcomes—nearly double that of Saxenda—with the convenience of weekly rather than daily administration.

Head-to-head trials comparing semaglutide to liraglutide (SUSTAIN 10) showed that semaglutide users lost significantly more weight at equivalent treatment durations[8]. The enhanced potency and longer half-life of semaglutide explain what Wegovy does that makes it the most effective pharmacological option currently available for chronic weight management in the UK. All prescription weight loss medications available through Cured Pharmacy require clinical assessment by our UK-registered prescribers to ensure suitability and safety.

What Does Wegovy Do for Long-Term Weight Maintenance?

A critical question many patients have is what does Wegovy do after you've lost the weight—can it help you keep it off? The STEP 4 trial specifically addressed this by randomising participants who had already lost weight on Wegovy to either continue treatment or switch to placebo[2]. Those who continued Wegovy maintained their weight loss and lost an additional 7.9% over the following 48 weeks, whilst the placebo group regained 6.9% of their body weight.

This trial demonstrates that what Wegovy does extends beyond initial weight reduction—it provides ongoing appetite regulation and metabolic support that helps prevent the weight regain typically seen after diet-induced weight loss. Current MHRA and NICE guidance supports long-term Wegovy use for chronic weight management, recognising obesity as a chronic relapsing condition that often requires sustained pharmacological intervention alongside lifestyle modification. Treatment duration should be determined by your prescriber based on individual response, tolerability, and ongoing clinical need.

What Does Wegovy Do If You Stop Taking It?

Understanding what does Wegovy do when discontinued is important for setting realistic expectations. The STEP 4 withdrawal data shows that most patients experience gradual weight regain when semaglutide is stopped, typically regaining 5-7% of body weight within 12 months[2]. This reflects the return of underlying appetite dysregulation rather than a rebound effect from the medication itself. For sustainable results, most patients require ongoing treatment combined with maintained lifestyle changes, though some individuals may successfully transition to lifestyle management alone after achieving significant weight loss and establishing new eating patterns.

What Does Wegovy Do in Terms of Side Effects and Safety?

No discussion of what does Wegovy do would be complete without addressing tolerability. The most common side effects are gastrointestinal: nausea (44% of users), diarrhoea (30%), vomiting (24%), and constipation (24%), typically most pronounced during dose escalation and diminishing over time[6]. These effects reflect semaglutide's action on gastric emptying and are generally mild to moderate in severity.

Serious adverse events are rare but include potential risks of pancreatitis, gallbladder disease, and in animal studies, thyroid C-cell tumours (though no causal link has been established in humans). Wegovy is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2[6]. What does Wegovy do to ensure safety? The medication should only be prescribed following comprehensive medical assessment by a UK-registered prescriber who can evaluate your individual risk factors, current medications, and medical history. At Cured Pharmacy, our clinical team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073) conducts thorough consultations before any prescription is issued.

Scientific References

  1. Wilding, J. P., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., ... & Kushner, R. F. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553-1564. [accessed 15 August 2026]
  2. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  3. Hjerpsted, J. B., Flint, A., Brooks, A., Axelsen, M. B., Kvist, T., & Blundell, J. (2018). Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity. Diabetes, Obesity and Metabolism, 20(3), 610-619. [accessed 15 August 2026]
  4. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., ... & Lingvay, I. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 15 August 2026]
  5. Blundell, J., Finlayson, G., Axelsen, M., Flint, A., Gibbons, C., Kvist, T., & Hjerpsted, J. B. (2017). Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism, 19(9), 1242-1251. [accessed 15 August 2026]
  6. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. [accessed 15 August 2026]
  7. National Institute for Health and Care Excellence. (2022). Obesity: identification, assessment and management [CG189]. NICE guideline. [accessed 15 August 2026]
  8. Pratley, R. E., Aroda, V. R., Lingvay, I., Lüdemann, J., Andreassen, C., Navarria, A., & Viljoen, A. (2018). Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. The Lancet Diabetes & Endocrinology, 6(4), 275-286. [accessed 15 August 2026]
  9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What does Wegovy do in the first month of treatment?
During the first month on Wegovy's 0.25mg starting dose, most patients notice reduced appetite and early weight loss of 2-4kg on average, though individual responses vary. The full effect develops as you progress through dose escalation to the 2.4mg maintenance dose.
What does Wegovy do differently from Ozempic?
Wegovy contains the same active ingredient (semaglutide) as Ozempic but at a higher maximum dose (2.4mg vs 1mg) and is specifically licensed for weight management, whereas Ozempic is licensed only for type 2 diabetes treatment in the UK.
What does Wegovy do if I don't change my diet?
Wegovy significantly reduces appetite and can produce weight loss even without deliberate dietary changes, but clinical trials show the best results occur when combined with a reduced-calorie diet and increased physical activity. Lifestyle modification enhances and sustains the medication's effects.
What does Wegovy do to blood sugar levels?
Wegovy improves glycaemic control by enhancing insulin secretion in response to meals and reducing glucagon release, which can lower HbA1c by 0.5-1.0% even in people without diabetes. This metabolic benefit contributes to reduced cardiovascular risk.
How long does it take to see what Wegovy does for weight loss?
Most patients notice appetite reduction within 1-2 weeks and measurable weight loss within the first month, with progressive results over 68 weeks as doses increase. Peak weight loss typically occurs around 60-68 weeks of continuous treatment.
What does Wegovy do that diet and exercise alone cannot?
Wegovy addresses the hormonal and neurological appetite dysregulation that makes sustained weight loss difficult through willpower alone, effectively lowering your biological set point for body weight. It doesn't replace healthy habits but makes them significantly easier to maintain.
Can I get Wegovy from Cured Pharmacy to see what it does for me?
Yes, Wegovy is available from Cured Pharmacy at £69.00 following a free online consultation with our UK-registered prescribers (under 3 minutes). Subject to clinical approval, we provide genuine UK-licensed Wegovy with discreet next-day delivery and £20 off your first order with code Weightlossnew.
What does Wegovy do for people who've failed other diets?
Clinical trials included many participants with previous unsuccessful weight loss attempts, and Wegovy demonstrated consistent efficacy regardless of dieting history. The medication addresses underlying biological mechanisms that often cause diet failure, providing pharmacological support for sustainable behaviour change.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.